In honor of the generosity of John and Jayne Simmons, the law school will be named Simmons Law School, pending approval from the SIU Board of Trustees in April.        

“If I’m going to be an obstruction, if I’m going to make your life more complicated, you’re going to avoid me,” said Mark Klein, general counsel of Burford Capital.        

“Adding a dedicated data privacy group with such a strong private equity background is the icing on the cake for our clients,” said Jane Arnold, co-chair of Polsinelli’s business department.        

John Rosenthal, chair of Winston’s eDiscovery and Information Governance Practice, and one of the members of the firm’s newly formed AI Strategy Group, discusses how the group evaluates generative AI-powered solutions and what he hopes the team will accomplish going forward.        

On Monday, the U.S. Court of Appeals for the Eleventh Circuit found that the EPA’s registration of Roundup did not carry the “force of law” that preempted Georgia plaintiff John Carson’s claims.        

Evidence presented to the jury outlined Ronnie Goldy’s transactional relationship with a woman that included “encounters and solicitations and acceptance of sexually explicit images and videos.”        

The three-judge panel reversed an order denying dismissal of the suit against the state officials, concluding current and former Oregon inmates’ vaccine prioritization claims were barred under the PREP Act.        

“These misrepresentations also ensured that Siemens was always on the ‘right side’ of its guarantees (falsely reflecting cost savings) to the HHC, which ensured that Siemens would not be held responsible for failing to deliver the energy savings that it promised when it sought HUD approval,” according to the plaintiffs’ complaint.        

“The discovery—after impaneling the jury—that a juror’s niece worked for Royal Caribbean triggered its duty to investigate the potential bias. But the district court did not do so,” Judge Barbara Lagoa wrote.        

Plaintiff’s counsel was was part of the team that persuaded a Missouri jury to award three plaintiffs who had non-Hodgkin lymphoma a total of $1.56 billion in November.